Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
Dive into the research topics where Gershon Golomb is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Nortriptyline-targeted siRNA-loaded liposomes: Design, affinity, biodistribution, and bioactivity in a murine Herpes Simplex Virus 1 corneal infection model
Jbara-Agbaria, D., Thathapudi, N. C., Groleau, M., Agbaria, M., Robert, M. C., Da Silva, N. C., Talbot, S., Laganiere, J., Griffith, M. & Golomb, G., 1 Feb 2026, In: European Journal of Pharmaceutical Sciences. 217, 107388.Research output: Contribution to journal › Article › peer-review
Open Access -
Formulation and evaluation of apolipoprotein B peptide-targeted siRNA liposomes against herpes simplex virus type 1: Delivery potential and limitations
Jbara-Agbaria, D., Agbaria, M. & Golomb, G., Dec 2025, In: Nano Trends. 12, 100162.Research output: Contribution to journal › Article › peer-review
Open Access -
Localized delivery of gel-embedded siRNA nanoparticles for pancreatic cancer treatment: Formulation, biodistribution, and bioactivity in mice
Agbaria, M., Jbara-Agbaria, D. & Golomb, G., 2025, In: Precision Nanomedicine. 8, 2, p. 1482-1500 19 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Targeting siRNA nanoparticles with ApoB peptide: Formulation, biodistribution, and bioactivity in pancreatic tumor-bearing mice
Agbaria, M., Jbara-Agbaria, D. & Golomb, G., Jun 2025, In: Journal of Drug Delivery Science and Technology. 108, 106900.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system
Reus, P., Guthmann, H., Uhlig, N., Agbaria, M., Issmail, L., Eberlein, V., Nordling-David, M. M., Jbara-Agbaria, D., Ciesek, S., Bojkova, D., Cinatl, J., Burger-Kentischer, A., Rupp, S., Zaliani, A., Grunwald, T., Gribbon, P., Kannt, A. & Golomb, G., Dec 2023, In: Journal of Controlled Release. 364, p. 654-671 18 p.Research output: Contribution to journal › Article › peer-review
Open Access10 Scopus citations